U.S. Marine and Shipping Stock News

Deluxe Corporation ( NYSE:DLX ) stock is about to trade ex-dividend in 3 days. The ex-dividend date is usually set to...

The healthy profit announcement from Spire Global, Inc. ( NYSE:SPIR ) didn't seem to impress investors. We think that...

SoundHound AI, Inc. ( NASDAQ:SOUN ) shareholders won't be pleased to see that the share price has had a very rough...

Even though Kodiak Gas Services, Inc. ( NYSE:KGS ) posted strong earnings, investors appeared to be underwhelmed. Our...

Mobix Labs, Inc. ( NASDAQ:MOBX ) shareholders that were waiting for something to happen have been dealt a blow with a...

There's been a major selloff in Microvast Holdings, Inc. ( NASDAQ:MVST ) shares in the week since it released its...

The stock price didn't jump after ACM Research, Inc. ( NASDAQ:ACMR ) posted decent earnings last week. We think that...

The market was pleased with the recent earnings report from Permian Resources Corporation ( NYSE:PR ), despite the...

AAON, Inc.'s ( NASDAQ:AAON ) stock showed strength, with investors undeterred by its weak earnings report. Sometimes...

Ever wondered if Exact Sciences is actually a bargain, or if the recent hype means you could be buying at the peak? Let’s unravel what today’s price really means for investors looking for value. The stock has caught some attention lately, climbing 15.2% in the past month and 20.1% year-to-date, with an impressive 34.8% gain over the last year. However, it is still down 39.2% from five years ago. Industry buzz has recently ramped up after Exact Sciences made headlines with strategic...

Diebold Nixdorf (NYSE:DBD) turned a profit in the third quarter, reversing last year’s loss and also growing revenue. Management reaffirmed full-year guidance and announced another round of share repurchases, which suggests ongoing confidence in the business. See our latest analysis for Diebold Nixdorf. Diebold Nixdorf’s recent run of positive news, including its return to profit, upbeat guidance, and fresh share buyback, seems to have reinforced investor optimism. The stock has posted a...

CEVA, Inc. ( NASDAQ:CEVA ) last week reported its latest quarterly results, which makes it a good time for investors to...

Campbell's (CPB) has caught fresh attention following the announcement of its limited-edition Sides Collection, launched in partnership with Cynthia Rowley and Kit Keenan. The collaboration merges culinary tradition with designer flair just in time for the holiday season. See our latest analysis for Campbell's. This designer collaboration has injected some fresh attention into Campbell's amid an otherwise challenging year, as reflected by a year-to-date share price return of -25.8% and a...

Legend Biotech reported third-quarter 2025 earnings, highlighting US$272.33 million in revenue and a net loss of US$39.69 million, alongside improved loss per share compared to the prior year. The company received an FDA label update for its CARVYKTI therapy, now including data showing significant survival benefits for patients with relapsed, refractory multiple myeloma, strengthening its clinical positioning. We’ll examine how the FDA label update for CARVYKTI, supported by positive...

It's been a sad week for Cannae Holdings, Inc. ( NYSE:CNNE ), who've watched their investment drop 10% to US$15.99 in...

SiriusPoint (SPNT) stock caught investors' attention after the company disclosed much stronger third quarter revenue and net income compared to last year. These results suggest improving operations and could explain recent upward movement in the share price. See our latest analysis for SiriusPoint. SiriusPoint’s momentum has been building throughout the year, thanks to standout results and a confident outlook. The 1-year total shareholder return has reached 39%, and the share price has risen...

BrightSpring Health Services (BTSG) has attracted increased attention after Wells Fargo raised its outlook, following a string of upward revisions from major banks in recent weeks. These moves highlight growing market confidence around the company’s prospects. See our latest analysis for BrightSpring Health Services. Momentum has been hard to ignore lately, with BrightSpring’s 30-day share price return of 14.1% and a huge 94.1% year-to-date gain. Recent upbeat analyst views and upcoming...

LPL Financial Holdings Inc. recently reported its third quarter 2025 results, showing revenue of US$4.55 billion but experiencing a net loss of US$29.52 million compared to net income a year earlier, alongside ongoing focus on acquisitions, organic growth investment, and a declared US$0.30 per share dividend. An interesting observation is that despite not repurchasing any shares in the latest quarter, LPL has completed over 36.42 million shares in buybacks since 2014, while also closing the...

Investors in Enviri Corporation ( NYSE:NVRI ) had a good week, as its shares rose 9.3% to close at US$13.35 following...

Calix, Inc. recently issued earnings guidance for its fourth quarter of 2025, projecting revenue between US$267 million and US$273 million, a midpoint that signals 2% sequential growth and 20% annual revenue expansion compared to 2024. This guidance, which reflects ongoing demand for Calix’s broadband and cloud platforms, underscores management’s confidence in near-term growth amid a competitive market landscape. With Calix’s revenue outlook now confirmed, we'll assess how stronger near-term...

On November 12, 2025, CorMedix Inc. reported a very large year-over-year increase in third quarter revenue to US$104.28 million and net income of US$108.56 million, while also issuing net revenue guidance of US$115 million to US$135 million for the fourth quarter ending December 31, 2025. This dramatic move from a net loss to a significant net profit highlights a sharp turnaround in the company’s operational and financial performance over the past year. We’ll examine how this transformation...

Credit Acceptance Corporation reported third quarter results in the past, with revenue rising to US$582.4 million and net income reaching US$108.2 million, both higher than the previous year, alongside the completion of a significant share repurchase program totaling over 1.83 million shares since 2023. The combination of improved earnings and active buybacks may indicate both operational momentum and management's confidence in the company’s longer-term prospects. We'll examine how Credit...

Abeona Therapeutics recently reported a third-quarter 2025 net loss of US$5.16 million, a significant improvement from US$30.27 million a year earlier, as its efforts to commercialize ZEVASKYN for RDEB patients advance alongside expanded treatment center access. A pivotal development includes the Centers for Medicare and Medicaid Services establishing a permanent J-code for ZEVASKYN, poised to support broader reimbursement and access from January 2026. With a 17.90% weekly and 18.47% daily...

Earlier this month, Catalyst Pharmaceuticals reported third quarter 2025 earnings, revealing a rise in both revenue and net income year-over-year, and raised its full-year revenue guidance to between US$565 million and US$585 million. This guidance boost and continued financial progress highlight ongoing business momentum, with product demand and patient reach playing important roles in recent performance. We'll explore how Catalyst Pharmaceuticals' improved full-year revenue forecast may...